Bravo Pharma Officially Partners with G42 Healthcare to Spearhead the Field of Genomics
Abu Dhabi, UAE, April 5th, 2023, ZEXPRWIRE, World-leading healthcare specialists Bravo Pharma have officially entered a strategic partnership with the region’s pioneering AI-powered healthcare company G42 Healthcare. In addition to this partnership, Bravo Pharma has also organized and participated with G42 Healthcare in a Conference dedicated to Clinical Genomics, Proteomics and Somalogic at Republicans Oncology Centre Tashkent Uzbekistan, attended by doctors from various oncology regional hospitals and the specialists from G42 Healthcare Abu Dhabi, Dr. Azza Attia and Mohd Rafiq M Zuraiqi.
Furthermore, they participated in the inaugural ceremony of the first Reference Oncology Diagnostic center which has been established by Bravo Pharma Group in association with Republicans Oncology Centre Tashkent Uzbekistan. The ceremony was attended by Indian Ambassador H.E Shri Manish Prabhat, Director Oncology Mirza Ghalib Tillyashaykhov and other office bearers.
G42 Healthcare, the leading Abu Dhabi-based health-tech company, aims to transform the traditional healthcare ecosystem across the region and beyond, by harnessing AI and advanced medical technologies. In line with its mission to unlock the potential of personalized and preventive care, G42 Healthcare has established Biogenix Labs, UAE’s first COVID-19 accredited large-scale throughput laboratory, launched IROS, the region’s first contract research organization for clinical research, and set up the Omics Centre of Excellence, the region’s largest and most technologically advanced Omics facility.
For Bravo Pharma, this strategic partnership with G42 Healthcare signals an increased effort in creating AI-based health services across the region and beyond through best-in-class integrated and multidisciplinary care in Central Asia, Africa and India by building highly efficient clinical reporting systems using bioinformatics and AI.
Bravo Pharma CMD Rakesh Pandey, a well-known entrepreneur and social philanthropist has been the center of the company’s operations on extending the field of genomics and pre diagnosis of solid cancer both geographically and research wise.
Regarding the collaboration, he stated, “For us, this partnership comes as a step closer to our mission of taking healthcare to the next level. As time and technology advance, we have the duty to provide everyone with the best and leading healthcare possible to ensure the highest quality of life for all. With G42 Healthcare’s AI development and our core new drug discovery cytogenetic, targeted therapy and advanced diagnostics competencies, we will be able to spearhead the region’s genome and health data computation processes.”
Kareem Shahin, Chief Business Officer, G42 Healthcare commented, “Joining hands with Bravo Pharma strengthens our unified vision for a more personalized, intelligent, and value-based healthcare model. The impactful collaboration will enable us to deploy our best-in-class sequencing technologies to provide clinical genomics sequencing services coupled with clinical reporting and bioinformatics to propel healthcare forward.”
About Bravo Pharma
Bravo Pharma is a UK-based, global healthcare company, leading the field of genome sequencing solutions, advanced diagnostics, equipment and research. They utilize the world’s most modern and innovative technologies in drug development, targeted therapy, and non-invasive diagnostics to deliver the utmost quality of life to all.
ZEX PR Wire offers massive Press Release, News, Authored Articles, Editorial services, geared at generating massive exposure for your unique project, business, or concept.
ZEX PR WIRE is a premium press release distribution provides end-to- end solutions to produce, optimize and target content and then distribute and measure results. Combining the world's largest multi-channel, multi-cultural content distribution and optimization network with comprehensive workflow tools and platforms, ZEX PR WIRE serves tens of thousands of clients from offices in the Americas, Europe, Middle East, Africa and Asia-Pacific regions.
Disclaimer: ZEXPRWIRE is a newswire distribution network. Articles and other content published by ZEXPRWIRE are the legal responsibility of the author and ZEXPRWIRE accepts no liability for the content of such material. ZEXPRWIRE publishes content for informational purposes and makes no representations regarding, recommendation or invitation to engage in, any form of financial or investment activity, and does not endorse the content of any material published.
ZEX PR WIRE allows users to submit their press releases through our online platform. Once submitted, our team reviews the content for quality and relevance. Upon approval, the press release is distributed to our extensive network, including major news outlets, industry-specific publications, and online platforms.
You can streamline the distribution process while still benefiting from human oversight. This ensures that your press releases meet quality standards, increasing the likelihood of media coverage and enhancing your brand's visibility.
ZEX PR WIRE accepts a wide range of press releases, including product launches, company announcements, event promotions, new partnerships, industry insights, and more. However, we do not accept press releases containing offensive or illegal content. For more information on this please visit https://zexprwire.com/editorial-guidelines/
Pricing for using ZEX PR WIRE varies depending on the distribution package you choose. We offer different plans to suit various needs and budgets. For detailed pricing information, please visit https://pr.zexprwire.com/pricing
You can view the total number of site submissions, status for each submission (live/pending), hyperlinks for each live PR, details pertaining to your package and number of press releases remaining, and view count for each live PR through third-party tracker integrations. (You may change the content according to what we provide in analytics).
ZEX PR Wire operates between 10AM to 7PM IST. During these hours, press releases may be distributed immediately after editorial approval of the press release. Otherwise, it will be published the next day. Additionally, several publications might require more than one day to be completed.
It generally takes 24- 72 hrs to publish the press release and generate the report
Yes, ZEX PR WIRE allows you to schedule the distribution of your press release for a specific date and time. This feature enables you to plan your PR campaigns strategically and ensure that your news reaches the right audience at the right time.
If you have any further questions or need assistance, you can reach out to our customer support team through direct Whatsapp ,chat on the web or can write to us at [email protected]. We are available to help you with any queries or concerns you may have.